CM

Casey Matthews

Vice President Of Daedamab Business Development at Alloy Therapeutics

Casey Matthews has a diverse work experience in various roles and industries. Currently, they are working as the Vice President of Daedamab Business Development at Alloy Therapeutics, Inc. They previously held the position of Senior Director of Business Development and Sales at the same company. Prior to that, Casey worked as a Senior Territory Account Manager at DNA Script.

Their longest tenure was at Roche, where they held multiple positions. They started as a Laboratory Technician at Salisbury University. They then worked at the NIH Intramural Research Program as an IRTA Fellow, where they investigated neurological mechanisms of drug addiction & abuse. Casey then moved to SAIC as a Research Associate II, managing and maintaining the NGS pipeline. At the University of Maryland School of Medicine, they served as the Sequencing Platform Technical Lead.

Casey's experience at Roche includes roles such as Lead Field Application Specialist, Senior Sequencing Solutions Specialist, and Marketing & Product Manager. In these positions, they demonstrated success in sales activities, customer training, and building relationships. They also contributed to strategic planning and management of high-value accounts.

Overall, Casey Matthews has a strong background in business development, sales, and technical operations, with experience in the life sciences industry.

Casey Matthews holds an MS degree in Biotechnology with a concentration in Biodefense from The Johns Hopkins University, obtained from 2006 to 2008. Prior to that, Casey earned a BS degree in Biology with a concentration in Chemistry from Salisbury University, from 2001 to 2003. Casey also has additional certifications, including a ClickUp Novice Certificate of Completion (expected in 2024) and Statistics Foundations Certifications 1 and 2 (obtained in 2021) from LinkedIn.

Links

Previous companies

Roche logo
SAIC logo
Salisbury University logo

Timeline

  • Vice President Of Daedamab Business Development

    December, 2023 - present

  • Senior Director Of Business Development And Sales

    February, 2022